Free Trial
ASX:LOV

Lovisa (LOV) Stock Price, News & Analysis

Lovisa logo

About Lovisa Stock (ASX:LOV)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
593,175 shs
Average Volume
N/A
Market Capitalization
A$3.20 billion
P/E Ratio
38.45
Dividend Yield
3.01%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lovisa and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LOV Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.tc pixel
See More Headlines

LOV Stock Analysis - Frequently Asked Questions

Lovisa Holdings Limited (ASX:LOV) issued its earnings results on Wednesday, February, 20th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.26 by $0.02. Lovisa had a net margin of 11.80% and a trailing twelve-month return on equity of 89.46%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lovisa investors own include Alpine Immune Sciences (ALPN), Affiliated Managers Group (AMG), Bristol Myers Squibb (BMY), CVS Health (CVS), Danaher (DHR), Livongo Health (LVGO) and Macerich (MAC).

Company Calendar

Last Earnings
2/20/2019
Ex-Dividend for 10/15 Dividend
9/14/2025
Today
9/17/2025
Record date for 10/15 Dividend
10/15/2025
Dividend Payable
10/15/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Specialty Retail
Sub-Industry
Business Services
Current Symbol
ASX:LOV
CIK
N/A
Fax
N/A
Employees
270
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.74
Trailing P/E Ratio
38.45
Forward P/E Ratio
N/A
P/E Growth
1.39
Net Income
A$82.41 million
Net Margins
11.80%
Pretax Margin
N/A
Return on Equity
89.46%
Return on Assets
15.53%

Debt

Debt-to-Equity Ratio
447.23
Current Ratio
0.93
Quick Ratio
0.40

Sales & Book Value

Annual Sales
A$698.66 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
27.07
Book Value
A$0.73 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
110,720,000
Free Float
N/A
Market Cap
A$3.20 billion
Optionable
Not Optionable
Beta
1.87
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (ASX:LOV) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners